» Articles » PMID: 38988971

Comprehensive Analysis of Cancer Incidence and Mortality Trends in Costa Rica: Implications for Public Health

Overview
Journal J Cancer Ther
Date 2024 Jul 11
PMID 38988971
Authors
Affiliations
Soon will be listed here.
Abstract

This commentary delves into the evolving landscape of cancer incidence and mortality in Costa Rica, presenting a comprehensive analysis of the data. Key findings reveal a concerning upward trajectory in cancer incidence rates, placing Costa Rica at the forefront within Central America. While prostate cancer and breast cancer dominate, disparities emerge when scrutinizing gender-specific trends. Notably, stomach and cervical cancers show declines, potentially attributed to targeted interventions. However, colorectal and liver cancers witness mortality increases, necessitating strategic responses. Geographical disparities persist across provinces, highlighting the need for equitable healthcare access. In conclusion, this commentary underscores the urgency of addressing the burgeoning cancer burden in Costa Rica, calling for evidence-based interventions and collaborative efforts on a global scale.

References
1.
Makarova-Rusher O, Altekruse S, McNeel T, Ulahannan S, Duffy A, Graubard B . Population attributable fractions of risk factors for hepatocellular carcinoma in the United States. Cancer. 2016; 122(11):1757-65. PMC: 5548177. DOI: 10.1002/cncr.29971. View

2.
Ward E, DeSantis C, Robbins A, Kohler B, Jemal A . Childhood and adolescent cancer statistics, 2014. CA Cancer J Clin. 2014; 64(2):83-103. DOI: 10.3322/caac.21219. View

3.
Calderon A, Guzman P, Murphy J . Epidemiological Patterns of Common Cancers in Costa Rica: An Overview up to 2020. Open J Soc Sci. 2023; 11(6):500-517. PMC: 10475317. DOI: 10.4236/jss.2023.116033. View

4.
Bray F, Ferlay J, Soerjomataram I, Siegel R, Torre L, Jemal A . Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018; 68(6):394-424. DOI: 10.3322/caac.21492. View

5.
Herrero R, Quint W, Hildesheim A, Gonzalez P, Struijk L, Katki H . Reduced prevalence of oral human papillomavirus (HPV) 4 years after bivalent HPV vaccination in a randomized clinical trial in Costa Rica. PLoS One. 2013; 8(7):e68329. PMC: 3714284. DOI: 10.1371/journal.pone.0068329. View